ELPA President Marko Korenjak was personally invited by Theresia Bauer, the Minister of Science, Research and Arts of the State of Baden-Württemberg, Germany to the online-event: “No one size fits all: Artificial Intelligence as Key Technology for Personalised Medicine”.
On July 3, he, as ELPA representative, had the possibility to discuss with high-level distinguished panellists the interfaces between AI and medicine, the cooperation between science and industry as well as the future funding instruments for health and AI planned by the European Commission.
After an introduction by Bodo Lehmann, Head of the Representation of the State of Baden-Württemberg to the European Union and Dr. Julia Stamm, Founder and Director, Science Leads, Berlin, the keynote speech was delivered by Minister Theresia Bauer and Prof. Dr. Bernhard Schölkopf, Director, Max Planck Institute for Intelligent Systems.
Dr. Karim Berkouk, Deputy Head of Unit Combatting Diseases, DG Research and Innovation, European Commission, underlined the link between AI and health,
Artificial intelligence is one of the technologies that are key to Europe’s future as stressed during the debate by Dr. Nuria Oliver, Chief Data Scientist, Data-Pop Alliance, Member of the Board of ELLIS Society (European Laboratory for Learning and Intelligent Systems), and by Dr. Oliver Stegle, Head of Division, Computational Genomics and Systems Genetics, German Cancer Research Center Heidelberg and European Molecular Biology Laboratory Heidelberg.
In addition, personalised medicine is one out of many key applications of this modern data-driven approach to healthcare. Cross-disciplinary collaboration and a strong European network of AI hubs are needed to lever the full potential of AI. During the final session of the meeting Michael Vorländer, Head of Unit Education and Research, Permanent Representation of Germany to the European Union focused on the priorities in research and innovation under the German EU Council Presidency.